Sex-Based Differences in the Effect of Short Dual Antiplatelet Therapy Followed by Prasugrel Monotherapy in High-Bleeding-Risk Patients After Percutaneous Coronary Intervention
Background: In patients at high bleeding risk (HBR), short dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) reduces bleeding without increasing ischemic events. However, the sex-based differences in the effects of short DAPT strategy followed by prasugrel monotherapy compared with conventional DAPT strategy remain unclear.
Authors
- Anna Tsutsui (ORCID: https://orcid.org/0000-0001-7696-3717)
- Satoru Abe
- Go Kato
- Ken Kozuma
- Masayuki Fukuzawa
- Raisuke Iijima
- Norihiro Kogame
- Yoshitaka Murakami
- Masato Nakamura
- Yoshihisa Nakagawa
Institutions
- Toho University (JP)
- Shiga University of Medical Science (JP)
- Toho University Ohashi Medical Center (JP)
- Daiichi Sankyo (United Kingdom) (GB)
- Tokyo Rosai Hospital (JP)
- Teikyo University (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1253/circrep.cr-25-0298
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
- Daiichi Sankyo Europe